Baidu
map

全国人大代表、中科院院士姚建年: 加强知识产权保护至关重要

2015-03-16 陆琦 中国科学报

“加强知识产权保护,对优化创新环境,鼓励创造和创新,充分发挥知识创新在引导产业结构调整与升级、促进创新能力提升具有举足轻重的作用,也为贯彻实施创新驱动发展战略和建设创新型国家提供有力支撑。”经过参加专利法执法检查和调研,全国人大代表、中科院院士姚建年深切体会到,知识产权越来越成为提升我国科技竞争力的关键性因素。 专利法从1984年开始实施,经历了3次重大修订,在我国知识产权保




“加强知识产权保护,对优化创新环境,鼓励创造和创新,充分发挥知识创新在引导产业结构调整与升级、促进创新能力提升具有举足轻重的作用,也为贯彻实施创新驱动发展战略和建设创新型国家提供有力支撑。”经过参加专利法执法检查和调研,全国人大代表、中科院院士姚建年深切体会到,知识产权越来越成为提升我国科技竞争力的关键性因素。

专利法从1984年开始实施,经历了3次重大修订,在我国知识产权保护方面发挥了至关重要的作用。各级政府一直以来重视专利法配套制度和政策法规建设,不断完善激励专利创造和运用,不断加强专利公共服务,培植发展中介服务,加强对专利的保护,专利综合实力快速增长,创新环境持续优化。

然而,姚建年指出,我国对知识产权的保护还存在一些问题。从行业角度看,我国发明专利授权量与美国等发达国家相比,仍然存在较大差距。

从企业角度看,我国国内企业专利授权数量仍处于较低水平。2007~2011年我国国内企业发明专利授权占国内发明专利授权比重不足50%,而美国在2004~2008年这一比重已经接近90%。

从高校和科研机构角度看,我国高校和科研机构的基础研究能力特别是原始创新能力仍然不足。高校前50位申请人包括美国高校27所,日本和韩国高校各6所,而中国高校只有清华大学和北京大学。

此外,专利维权举证难、周期长、赔偿低、效果差的现象仍然存在。专利转化运用效果不理想,国有科研机构、高等院校的专利转化面临政策障碍,科研人员转化实施专利的热情和积极性不高。企事业单位、高校、科研机构知识产权人才普遍缺乏。

针对这些问题,姚建年建议,增强知识产权保护意识,从制度环境上鼓励高校、科研机构多与企业合作,促进产、学、研创新人才的交流合作,激发协同创新能力和创新活力。充分调动科研人员转化科技成果的积极性和主动性,让创新成果能够持续涌现,促进创新成果真正转化为价值创造能力。同时采取更为灵活的奖励机制和方法,切实保障研发人员的权益,更有效地激发发明人的创新活力和热情。

此外,姚建年还建议,加强专利保护力度,不断创新专利行政执法模式(如快速维权机制等),充分发挥司法作用,探索加大对侵权行为的判罚力度,规范市场竞争秩序。加强专利行政管理机构和专利服务体系建设,加强知识产权相关的专门人才培养,使专利服务机构能够满足企业专利纠纷解决、专利战略咨询等服务需求。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    good

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    good

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    不错,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]
    2015-10-24 gous
  9. [GetPortalCommentsPageByObjectIdResponse(id=1914056, encodeId=deff19140560c, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Wed Aug 05 11:42:00 CST 2015, time=2015-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56334, encodeId=52fd56334b4, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56335, encodeId=54ef5633545, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56336, encodeId=349f56336b2, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56337, encodeId=9d2c5633ebe, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56338, encodeId=263556338f3, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:44:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085155, encodeId=6bc02085155b2, content=<a href='/topic/show?id=2b3f2450e2e' target=_blank style='color:#2F92EE;'>#产权保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24507, encryptionId=2b3f2450e2e, topicName=产权保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac59108, createdName=hxj0117, createdTime=Fri Feb 12 08:42:00 CST 2016, time=2016-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1862517, encodeId=d198186251e97, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Oct 24 22:42:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591935, encodeId=9c2e159193593, content=<a href='/topic/show?id=271be3162a8' target=_blank style='color:#2F92EE;'>#知识产权#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73162, encryptionId=271be3162a8, topicName=知识产权)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d5d18047377, createdName=lixiaol, createdTime=Wed Mar 18 01:42:00 CST 2015, time=2015-03-18, status=1, ipAttribution=)]

相关资讯

连云港正大天晴三年完胜知识产权诉讼案

“最高人民法院的行政裁定书驳回了百时美施贵宝的再审申请,维持了北京高院的判决。”正大天晴药业集团知识产权总监耿文军昨日告诉记者,经过三年多的抗诉,正大天晴全面赢得了与百时美施贵宝的“恩替卡韦片”(商品名为“润众”)专利之争。百时美施贵宝针对正大天晴的专利侵权诉讼不仅被驳回,涉案专利更被认定为全部无效。这标志着随着我国企业知识产权意识的提高,中国企业更加自信地应对跨国企业知识产权诉讼。 这一切的缘

专利侵权判定原则-什么情况下会造成侵权

专利侵权判定原则中国知识产权保护体系采用双轨制,即行政保护和司法保护相结合。被侵权人可以把侵权人的侵权行为诉之于法院,也可以请求行政机关处理。行政程序并不是司法程序的前置程序。中国的司法体系采取二审终审制,大多数知识产权案件的一审法院为中级人民法院,我国于2014年底先后成立了三家知识产权法院(北京、广州、上海),日后的知识产权案件将由知识产权法院和中级法院共同管辖审理。一、如下情形,不视为侵犯专

2014年你一定要知道的知识产权那点事

 2014年发生了很多具有广泛社会影响的知识产权事件,这里,我们仅挑选10个最具代表性的事件,一起来回顾下吧:(排名不分先后)一、知识产权法院成立在今年的11月6日、12月15日、12月28日,北京、广州、上海知识产权法院相继成立。知识产权法院是我国目前设有的军事法院、海事法院、铁路运输法院之外的另一种专门人民法院,主要审理各类专利以及植物新品种、集成电路布图设计、技术秘密等知识产权民事

影响世界的发明

影响世界的发明(摘自国家知识产权局)创可贴的发明埃尔•迪克森(Earle Dickson)创可贴,日常生活中常用的一种外科用药,可方便、简捷地处理伤口。创可贴由埃尔•迪克森于1920年发明。埃尔•迪克森在帮助妻子包扎伤口时,萌发了制作一种自助包扎伤口绷带想法。他考虑到,如果把纱布和绷带做在一起,就能用一只手包扎伤口。经过反复试验,他采用了一种粗硬纱布,在上面涂上胶,然后把另一条纱布折成纱布垫,

科研工作者需谨记专利的重要性

专利制度是国际上通行的一种国家利用法律和经济手段保护发明创造者的合法权益,鼓励发明创造,推动科学技术进步的一项重要法律制度。知识产权日益成为国家发展的战略性资源和核心要素,在激励创新、推动经济发展和社会进步中的支撑作用日益凸显。1、专利的价值专利是一种无形财产权,受到法律的保护,具有价值和使用价值,有些重大专利的价值要远远高于房屋、汽车等有形财产。专利即是盾,保护自己的技术和产品,也是矛,可以

各国及各行业的专利申请状况

各国及各行业的专利申请状况 (摘自国家知识产权局) 随着知识经济和经济全球化深入发展,知识产权日益成为发展的重要资源和竞争力的核心要素,截至2013年,我国发明专利申请量连续3年居世界首位,知识产权对经济转型发展的推动作用不断凸显,对创新驱动发展战略的支撑作用不断增强。 如下数据可显现出近年来国家及各行业对专利的重视程度: 2014年国内发明专利受理状况:

Baidu
map
Baidu
map
Baidu
map